Structural basis for channel gating and blockade in tri-heteromeric GluN1-2B-2D NMDA receptor
Neuron · 2025-04 · 113 (7) · 991-1005.e5
DOI: 10.1016/j.neuron.2025.01.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2025-04. Verfasst von Hyunook Kang und 8 weiteren Autor:innen. Beteiligte Einrichtung: W.M. Keck Structural Biology Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Ion Channel Gating, Nerve Tissue Proteins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NINDS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Discrete activation of N-methyl-D-aspartate receptor (NMDAR) subtypes by glutamate and the co-agonist glycine is fundamental to neuroplasticity. A distinct variant, the tri-heteromeric receptor, comprising glycine-binding GluN1 and two types of glutamate-binding GluN2 subunits, exhibits unique pharmacological characteristics, notably enhanced sensitivity to the anti-depressant channel blocker S-(+)-ketamine. Despite its significance, the structural mechanisms underlying ligand gating and channel blockade of tri-heteromeric NMDARs remain poorly understood. Here, we identify and characterize tri-heteromeric GluN1-2B-2D NMDAR in the adult brain, resolving its structures in the activated, inhibited, and S-(+)-ketamine-blocked states. These structures reveal the ligand-dependent conformational dynamics that modulate the tension between the extracellular domain and transmembrane channels, governing channel gating and blockade. Additionally, we demonstrate that the inhibitor (S)-DQP-997-74 selectively decouples linker tension in GluN2D, offering insights into subtype-selective targeting for cognitive modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- W.M. Keck Structural Biology Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
- Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, USA.
- Department of Chemistry, Emory University, Atlanta, GA, USA.
- Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, GA, USA; Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, GA, USA.
- W.M. Keck Structural Biology Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA. Electronic address: furukawa@cshl.edu.
Förderung
- NIMH NIH HHS
- NINDS NIH HHS
- NIH HHS
- NIMH
- National Research Foundation of Korea
- NINDS
- NIH
Zitieren
APA
Kang, H., Epstein, M., Banke, T. G., Perszyk, R., Simorowski, N., Paladugu, S., Liotta, D. C., Traynelis, S. F., & Furukawa, H. (2025). Structural basis for channel gating and blockade in tri-heteromeric GluN1-2B-2D NMDA receptor. Neuron, 113(7), 991-1005.e5. https://doi.org/10.1016/j.neuron.2025.01.013
Vancouver
Kang H, Epstein M, Banke TG, Perszyk R, Simorowski N, Paladugu S, et al. Structural basis for channel gating and blockade in tri-heteromeric GluN1-2B-2D NMDA receptor. Neuron. 2025;113(7):991-1005.e5. doi:10.1016/j.neuron.2025.01.013
BibTeX
@article{Kang2025,
author = {Kang, Hyunook and Epstein, Max and Banke, Tue G and Perszyk, Riley and Simorowski, Noriko and Paladugu, Srinu and Liotta, Dennis C and Traynelis, Stephen F and Furukawa, Hiro},
title = {Structural basis for channel gating and blockade in tri-heteromeric GluN1-2B-2D NMDA receptor},
journal = {Neuron},
year = {2025},
volume = {113},
number = {7},
pages = {991--1005.e5},
doi = {10.1016/j.neuron.2025.01.013}
}
EUVIMED